Effectiveness of mesalamine and propolis in experimental colitis
โ Scribed by Ahmet Aslan; Muhyittin Temiz; Esin Atik; Gurbuz Polat; Nuray Sahinler; Elmir Besirov; Nedim Aban; Cem Kaan Parsak
- Publisher
- Springer Healthcare Communications
- Year
- 2007
- Tongue
- English
- Weight
- 310 KB
- Volume
- 24
- Category
- Article
- ISSN
- 0741-238X
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Background: Many patients with ulcerative colitis (UC) respond to mesalamine therapy within 8 weeks. Those not achieving remission after 8 weeks are often treated with steroids or other immunosuppressive therapies. This study aimed to determine the effect of 8 weeks' high-dose MMX mesalamine extensi
On 20 July 2006 a 17-year-old male was admitted to our critical care unit for the treatment of painful eruptions on his trunk, resembling toxic epidermal necrosis (TEN). On 13 June 2006 he had been diagnosed with ulcerative colitis (UC) and was hospitalized on 28 June 2006 for treatment of an acute